Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interferon and heparan sulphate.

H Lortat-Jacob1

  • 1Institut de Biologie Structurale UMR 5075 CEA-CNRS-UJF, Grenoble, France. Hugues.Lortat-Jacob@ibs.fr

Biochemical Society Transactions
|May 20, 2006
PubMed
Summary

Scientists discovered that heparan sulphate (HS) binding sites on interferon-gamma (IFNγ) can be mimicked. This breakthrough offers a new strategy to inhibit IFNγ activity in diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Virus and heparan sulphate: from adsorption mechanism to cellular entry].

Virologie (Montrouge, France)·2021
Same author

Chondroitin sulfates and their binding molecules in the central nervous system.

Glycoconjugate journal·2017
Same author

Desorption electrospray ionization mass spectrometry of glycosaminoglycans and their protein noncovalent complex.

Analytical chemistry·2010
Same author

The adenovirus type 3 dodecahedron's RGD loop comprises an HSPG binding site that influences integrin binding.

Journal of biomedicine & biotechnology·2010
Same author

Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy.

Biochimica et biophysica acta·2005
Same author

BIACORE data processing: an evaluation of the global fitting procedure.

Analytical biochemistry·2001

Area of Science:

  • Immunology
  • Glycobiology
  • Biochemistry

Background:

  • Interferons (IFNs) are cytokines discovered in 1954, crucial for antiviral defense and immune modulation.
  • Type I IFNs (IFNα, IFNβ) share structural similarity and a common receptor.
  • Type II IFN (IFNγ) is structurally distinct, binds a separate receptor, and interacts with heparan sulphate (HS).

Purpose of the Study:

  • To elucidate the structural basis of IFNγ binding to HS.
  • To develop novel inhibitors of IFNγ activity by mimicking its HS binding site.
  • To validate HS as a target for therapeutic intervention in IFNγ-mediated diseases.

Main Methods:

  • Characterization of IFNγ's interaction with HS, focusing on its binding site determinants.
  • Synthesis of glycoconjugate molecules designed to mimic the IFNγ-HS binding interface.
  • Assay of synthesized molecules for their ability to inhibit IFNγ binding to HS and the IFNγ receptor (IFNγR).

Main Results:

  • Identified a specific N-acetylated glucosamine-rich domain within HS that binds IFNγ.
  • Developed glycoconjugate mimetics that effectively mimic the IFNγ binding site on HS.
  • One synthesized molecule demonstrated high affinity for IFNγ, inhibiting its binding to both HS and the IFNγR.

Conclusions:

  • The study validates specific HS structural elements critical for IFNγ recognition.
  • The developed mimetics represent a novel strategy for inhibiting IFNγ.
  • This approach holds potential for treating diseases where IFNγ plays a detrimental role.

Related Experiment Videos